亚虹医药-U
(688176)
| 流通市值：71.41亿 | | | 总市值：71.41亿 |
| 流通股本：5.72亿 | | | 总股本：5.72亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 351,154,529.55 | 628,452,894.18 | 779,448,618.38 | 919,202,756.34 |
| 交易性金融资产 | 832,017,602.59 | 754,245,593.92 | 668,002,031.93 | 766,745,701.94 |
| 应收票据及应收账款 | 142,295,889.46 | 104,341,142.57 | 98,561,685.14 | 90,040,680.56 |
| 应收账款 | 142,295,889.46 | 104,341,142.57 | 98,561,685.14 | 90,040,680.56 |
| 预付款项 | 31,572,595.82 | 23,378,904.85 | 17,657,579.46 | 30,693,300.85 |
| 其他应收款合计 | 6,501,479.41 | 3,852,078.14 | 6,457,814.24 | 13,454,613.68 |
| 存货 | 25,012,628.53 | 18,006,043.39 | 21,918,308.62 | 11,738,356.57 |
| 一年内到期的非流动资产 | 84,539,987.82 | - | 10,926,750.04 | - |
| 其他流动资产 | 102,681,837.13 | 102,810,972.92 | 158,775,057.27 | - |
| 流动资产合计 | 1,575,776,550.31 | 1,635,087,629.97 | 1,761,747,845.08 | 1,831,875,409.94 |
| 非流动资产: | | | | |
| 其他债权投资 | - | 84,021,412.48 | 83,508,535.77 | 93,827,833.74 |
| 其他权益工具投资 | 16,162,888.39 | 31,254,272.2 | 16,346,414.02 | 20,334,910.39 |
| 其他非流动金融资产 | 35,000,000 | - | - | - |
| 固定资产 | 22,363,878.47 | 23,621,207.98 | 24,707,235.04 | 23,800,188.49 |
| 使用权资产 | 37,988,928.13 | 42,601,842.46 | 48,777,884.66 | 48,441,750.45 |
| 无形资产 | 109,031,969.99 | 68,970,892.12 | 73,677,559.63 | 78,672,688.67 |
| 开发支出 | - | 59,506,840 | - | - |
| 长期待摊费用 | 5,061,956.61 | 5,486,933.44 | 4,503,283.15 | 4,244,752.63 |
| 递延所得税资产 | 2,162,105.37 | 2,252,624.82 | 2,396,972.65 | 2,350,837.47 |
| 其他非流动资产 | 43,394,248.75 | 42,373,000.95 | 41,827,083.22 | 45,151,610.7 |
| 非流动资产合计 | 271,165,975.71 | 360,089,026.45 | 295,744,968.14 | 316,824,572.54 |
| 资产总计 | 1,846,942,526.02 | 1,995,176,656.42 | 2,057,492,813.22 | 2,148,699,982.48 |
| 流动负债: | | | | |
| 短期借款 | 90,255,028.03 | 200,286,546.54 | 238,502,995.44 | 260,985,966.9 |
| 应付票据及应付账款 | 45,266,421.98 | 52,687,514.31 | 59,590,132.91 | 28,579,815.41 |
| 应付账款 | 45,266,421.98 | 52,687,514.31 | 59,590,132.91 | 28,579,815.41 |
| 合同负债 | 1,040,882.78 | 221,238.94 | 221,238.94 | - |
| 应付职工薪酬 | 26,097,094.63 | 20,115,364.97 | 31,122,170.55 | 25,108,483.9 |
| 应交税费 | 6,749,050.51 | 3,947,310.12 | 3,624,808.1 | 6,265,962.16 |
| 其他应付款合计 | 50,015,813.18 | 105,150,743.75 | 50,129,594.11 | 30,233,026.04 |
| 一年内到期的非流动负债 | 24,765,791.66 | 18,972,195.58 | 19,205,609.04 | 16,124,247.86 |
| 流动负债合计 | 244,190,082.77 | 401,380,914.21 | 402,396,549.09 | 367,297,502.27 |
| 非流动负债: | | | | |
| 长期借款 | 205,205,575.98 | 104,206,569.69 | 48,435,258.14 | - |
| 租赁负债 | 29,388,503.25 | 33,821,667.72 | 39,003,436.15 | 40,252,268.96 |
| 递延收益 | 4,221,720.13 | 4,458,007.32 | 4,601,770.32 | 4,943,537.02 |
| 递延所得税负债 | 3,582.8 | - | - | - |
| 其他非流动负债 | 30,000,000 | - | - | - |
| 非流动负债合计 | 268,819,382.16 | 142,486,244.73 | 92,040,464.61 | 45,195,805.98 |
| 负债合计 | 513,009,464.93 | 543,867,158.94 | 494,437,013.7 | 412,493,308.25 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 572,192,168 | 571,170,486 | 571,170,486 | 571,170,486 |
| 资本公积 | 2,907,969,130.52 | 2,908,353,567.98 | 2,906,960,897.83 | 2,906,232,194.46 |
| 减:库存股 | 35,312,168.26 | 50,059,352.74 | 50,059,352.74 | 50,059,352.74 |
| 其他综合收益 | -7,334,409.29 | -5,323,029.43 | -6,737,198.31 | -5,279,139.05 |
| 未分配利润 | -2,083,600,017.75 | -1,957,393,762.48 | -1,844,995,257.84 | -1,677,562,029.33 |
| 归属于母公司股东权益合计 | 1,353,914,703.22 | 1,466,747,909.33 | 1,576,339,574.94 | 1,744,502,159.34 |
| 少数股东权益 | -19,981,642.13 | -15,438,411.85 | -13,283,775.42 | -8,295,485.11 |
| 股东权益合计 | 1,333,933,061.09 | 1,451,309,497.48 | 1,563,055,799.52 | 1,736,206,674.23 |
| 负债和股东权益合计 | 1,846,942,526.02 | 1,995,176,656.42 | 2,057,492,813.22 | 2,148,699,982.48 |
| 公告日期 | 2026-08-29 | 2026-04-30 | 2026-04-18 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |